Day One Biopharmaceuticals, Inc. (DAWN)
9.32
+0.14
(+1.53%)
USD |
NASDAQ |
Dec 31, 16:00
9.32
0.00 (0.00%)
After-Hours: 20:00
Day One Biopharmaceuticals Research and Development Expense (TTM): 169.01M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Mersana Therapeutics, Inc. | 68.92M |
| Iovance Biotherapeutics, Inc. | 303.64M |
| Lantheus Holdings, Inc. | 165.15M |
| iRhythm Technologies, Inc. | 82.64M |
| Perspective Therapeutics, Inc. | 61.22M |